In summary, while SERPINA1 elevation post-TACE occurs within an inflammatory context, our data collectively position it not as a passive bystander, but as a key effector molecule that is co-opted by residual tumor cells to drive a specific resistance program against the selective pressures of TACE. The gene discussed is SERPINA1; the disease is neoplasm.